Cargando…
Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes
Metronidazole (MTDZ), the drug of choice for the treatment of protozoal infections such as luminal amebiasis, is highly susceptible to colonic metabolism, which may hinder its conversion from a colon-specific prodrug to an effective anti-amebic agent targeting the entire large intestine. Thus, in an...
Autores principales: | Kim, Wooseong, Yang, Yejin, Kim, Dohoon, Jeong, Seongkeun, Yoo, Jin-Wook, Yoon, Jeong-Hyun, Jung, Yunjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317261/ https://www.ncbi.nlm.nih.gov/pubmed/28243064 http://dx.doi.org/10.2147/DDDT.S129922 |
Ejemplares similares
-
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
por: Yang, Yejin, et al.
Publicado: (2018) -
Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery
por: Lee, Yonghyun, et al.
Publicado: (2015) -
Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement
por: Yum, Soohwan, et al.
Publicado: (2015) -
Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target
por: Lee, Sunyoung, et al.
Publicado: (2015) -
Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
por: Kim, Wooseong, et al.
Publicado: (2019)